Mediwound to participate in fireside chat at h.c. wainwright 25th annual global investment conference

Yavne, israel, sept. 05, 2023 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced its participation in the upcoming h.c. wainwright 25th annual global investment conference. the conference will take place in new york city and virtually from september 11-13, 2023.
MDWD Ratings Summary
MDWD Quant Ranking